UPDATE 2-Merck wins $2.54 bln in hepatitis C drug trial against Gilead

Dec 15 (Reuters) - Merck & Co on Thursday was

awarded $2.54 billion in royalties by a federal jury in a patent

lawsuit against Gilead Sciences Inc over Gilead's

blockbuster hepatitis C drugs Sovaldi...

Read more